Cannabinoids have been demonstrated to exert neuroprotective effects on 2 different types of neuronal insults. Here we have addressed the therapeutic 3 potential of the synthetic cannabinoid HU210 on photoreceptor degeneration, 4 synaptic connectivity and functional activity of the retina in the transgenic P23H 5 rat, an animal model for autosomal dominant retinitis pigmentosa (RP). In P23H 6 rats administered with HU210 (100 µg/kg, i.p.) from P24 to P90, ERG 7 recordings showed an amelioration of vision loss, as compared to vehicle-8 administered animals. Under scotopic conditions, the maximum a-wave 9 amplitudes recorded at P60 and P90 were higher in HU210-treated animals, as 10 compared to the values obtained in untreated animals. The scotopic b-waves 11 were significantly higher in treated animals than in untreated rats at P30, P60 12 and P90. This attenuation of visual deterioration correlated with a delay in 13 photoreceptor degeneration and the preservation of retinal cytoarchitecture. 14 HU210-treated animals had 40% more photoreceptors than untreated animals. 15
cases. The P23H mutation in this gene is the most prevalent cause of RP (Dryja 8 et al., 1990) , which alone accounts for approximately 12% of autosomal 9 dominant RP cases in the United States (Dryja et al., 2000) . The majority of RP-10 causing mutations in the RHO gene, including P23H, cause misfolding and 11 retention of rhodopsin in the endoplasmic reticulum of transfected cultured cells 12 (Kaushal and Khorana, 1994) . These studies also suggest that the mechanism 13 of RP involves a cellular stress response (Illing et al., 2002) , the final common 14 pathway being programmed photoreceptor cell death, or apoptosis (Reme et 15 al., 1998) . P23H transgenic albino rats suffer from a progressive retinal 16 degeneration, which is consistent with the clinical findings in P23H patients 17 M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
For objective comparison, retinas from vehicle-and HU210-treated rats 1 were fully processed in parallel. All primary antibodies used in this work 2 (summarized in Table 1 ) have been used in several previous studies and have 3 been well characterized by us and other authors regarding specific cell type 4 molecular markers. Sections were subjected to single or double immunostaining 5 overnight at room temperature, with combinations of antibodies for different 6 molecular markers at the dilutions indicated in Table 1 , in PB containing 0.5% 7 Triton X-100. Subsequently, Alexa Fluor 488 (green)-conjugated anti-rabbit IgG 8 and/or Alexa Fluor 555 (red)-conjugated anti-mouse IgG donkey secondary 9
antibodies from Molecular Probes (Eugene, OR) were applied at a 1:100 10 dilution for 1 h. The sections were finally washed in PB, mounted in Citifluor 11 (Citifluor Ltd; London, UK) and coverslipped for viewing under laser-scanning 12 confocal microscopy on a Leica TCS SP2 system (Wetzlar, Germany). 13
Immunohistochemical controls were performed by omission of either the 14 primary or secondary antibodies. Final images from control and experimental 15 subjects were processed in parallel using the Adobe Photoshop 10 software 16 (Adobe Systems Inc., San Jose, CA). Unless otherwise indicated, all the images 17 analyzed were collected from the central area of the retina, close to the optic 18 nerve. 19 20
Morphometric analysis 21
Five animals per group were examined. For measurements of the outer 22 nuclear layer (ONL) thickness, a nuclear stain (Hoechst; Sigma, Milwaukee, WI) 23 was added at 1 µg/ml to at least 4 sections from each animal containing the 24 optic nerve and both temporal and nasal ora serratas. Counting of 25 M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
photoreceptor rows was performed each 0.5 mm from the optic nerve toward 1 each ora serrata. The number of photoreceptor rows was the average of three 2 measurements counting rows of nuclei of photoreceptor cells. For quantification 3 of the relative number of synaptic ribbons in the OPL, we counted the number 4 of Bassoon-immunoreactive puncta in 2 retinal sections from each animal 5 containing the optic nerve and both temporal and nasal ora serratas. 6
Measurements were performed close to the optic nerve, and at 2 and 4 mm 7 from the optic nerve toward each ora serrata. Total length of cones was 8 measured using γ-transducin stained retinal sections. Measurements were 9 performed in the central retina, temporal and nasal, close to the optic nerve, in 10 at least 5 cones from each animal. For evaluation of the ON-rod bipolar cells 11 integrity, we measured the intensity of PKC-α immunoreactivity using the 12 
HU210 preserves retinal responsiveness 2
In order to evaluate the effect of HU210 on the functional activity of the 3 retina in P23H rats, scotopic flash-induced ERG responses were recorded in 4 vehicle-and HU210-treated animals (n = 6 and n = 5, respectively). As shown in 5 Fig. 1 , ERG responsiveness was less deteriorated in P23H rats treated with 6 HU210 (P24 to P90), as compared to vehicle-administered P23H rats. The 7 maximum amplitudes recorded for a-waves at P60 and P90 under scotopic 8 conditions were higher in HU210-treated animals than those recorded in 9 untreated animals (ANOVA, Bonferroni's test, p < 0.05 in both cases; 
HU210 slows photoreceptor degeneration 2
To assess the protective action of HU210 on photoreceptors, we analyzed 3 the thickness of the ONL in each retina at P90. Figure 2 shows vertical sections 4 and magnifications of retinas from a P23H rat treated with HU210 (Fig. 2B) or 5 vehicle ( Fig. 2A) . Few rows of photoreceptor cell bodies could be observed in 6 the ONL of the vehicle-administered rats, as compared with the rows present in 7 the retina of the HU210-treated P23H animals. Because retinal degeneration in 8 untreated P23H rats was not homogeneous throughout the retina, we measured 9 the effects of HU210 in different retinal areas, from temporal to nasal. We found 10 that ONL thickness was greater in HU210-treated rats (n = 5) than in untreated 11 animals (n = 5) in all examined areas (Student's t-test, p < 0.01; Fig. 3A ). On 12 average, the mean number of photoreceptor rows in HU210-treated P23H rats 13 was 40% higher than observed in vehicle-administered P23H rats (2.6 ± 0.2 µm 14 vs. 1.8 ± 0.2 µm; Fig. 3A ). The mean number of rows of photoreceptor cell 15 bodies found in HU210-and vehicle-administered rat retinas positively 16 correlated with the maximum scotopic ERG b-wave amplitude recorded for each 17 animal at P90 (p < 0.01). 18
We next explored whether the conservation of photoreceptor number 19 was accompanied by a preservation of synaptic connectivity in the OPL. To this 20 end, we used antibodies against bassoon, a protein constituent of synaptic 21 ribbons present in both rod spherules and cone pedicles in the OPL (Cuenca et 22 al., 2004) . Few bassoon-immunopositive spots were found at the OPL level in 23 P23H untreated rats, as compared with the number of immunoreactive puncta 24 present in the retina of HU210-treated animals ( Fig. 7E, 7F ; arrows). SinceM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT retinal degeneration was not homogeneous throughout the retina in P23H rats, 1 we measured the relative number of positively stained ribbons in different retinal 2 areas, from temporal to nasal ( Figure 3B ). We found that the mean number of 3 Bassoon-immunoreactive puncta in HU210-treated P23H rats was 25% higher 4 (Student's t-test, p < 0.01) than observed in untreated animals (32.5 ± 2.6 vs. 5 26.0 ± 2.3 stained synaptic ribbons/100µm, n = 5 in both cases; Fig. 3B ), 6
indicating that the presynaptic contact elements between photoreceptors and 7 bipolar or horizontal cells were at least partially preserved. 8 9
HU210 preserves photoreceptor morphology 10
In order to evaluate whether HU210-treatment was able to preserve the 11 morphology of photoreceptors, we examined the staining pattern of antibodies 12 against recoverin, a marker for rods, cones and two bipolar cell subtypes 13 (Cuenca et al., 2004) , rhodopsin, which stains rod outer segments (Pinilla et al., 14 2007) , and γ-transducin, a marker for cones (Cuenca et al., 2004) . Longer rod 15 inner and outer segments were observed for HU210-treated P23H rats ( Fig. 4C ) 16 than for vehicle-administered animals ( Fig. 4B ), where rod degeneration was 17 evident to a greater degree. Drastic changes with age were also observed in 18 the cone photoreceptors of vehicle-administered P23H rats. At P90, their outer 19 segments were both short and swollen and very small in size (Fig. 4E, 4H ). The 20 axons were also absent and pedicles emerged directly from the cone cell 21 bodies. In contrast, the typical cone shape can be observed in HU210-treated 22 P23H rats (Fig. 4F, 4I ), where outer and inner segments were clearly identified 23 ( Fig. 4I ; arrows), and axon and pedicle morphology were preserved ( Fig. 4I ; 24 arrowheads). Mean length of cones in both treated and untreated P23H rats 25 M A N U S C R I P T
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was smaller than that observed in SD rats (Student's t-test, p < 0.01 in both 1 cases; Fig. 3C ). However, HU210-treated P23H rat retinas showed cone 2 photoreceptors 50% longer than in untreated P23H rat retinas (Student's t-test, 
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each one ending in a bulbous axon terminal in the S5 stratum (Fig. 5) . In the 1 retinas of vehicle-administered P23H rats, rod bipolar cells at P90 showed few 2 cell bodies and a retraction of their dendrites (Fig. 5B, 5E ). Dendritic branches 3 were scarce, and some cells had virtually no dendrites whatsoever. The number 4 of immunopositive cells appeared to decrease, and their cell bodies were not 5 aligned in the orderly fashion found in wild-type rats (Fig. 5A, 5D ). Moreover, a 6 loss of complexity and inmunoreativity can be obseved in the axon terminals of 7 these cells (Cuenca et al., 2004) . By contrast, in P23H HU210-treated animals, 8 bipolar cell dendrites were preserved ( Fig. 5C, 5F ; arrowheads), and the loss of 9 cell bodies was not so extensive. Increased PKC-α imnunoreactivity and larger 10 bulbous axon terminals, with lateral terminal varicosities, were found in central 11 and peripheral retina of HU210-treated rats (Fig. 5C, 5F ), as compared with 12 untreated animals (Fig. 5B, 5E ). Integrity of ON-rod bipolar cells was evaluated 13 by measuring in the central retina of each experimental group the relative 14 intensity of PKC-α immunoreactivity. As shown in Fig. 3D , ON-rod bipolar cells 15 immunoreactivity in SD rats was significantly greater (Student's t-test, p < 0.05) 16 than that obtained in untreated P23H rats (58.3% with respect to SD), but not 17 with respect to measured in HU210-treated animals (72.6% of the value in SD). 18 19
HU210 preserves photoreceptor axon terminals and their synaptic contacts 20 with bipolar cells 21
Given that photoreceptor morphology was preserved in HU210-treated rats, 22
we tested whether photoreceptor presynaptic terminals were protected by 23 HU210 treatment. To this end, we performed staining for synaptophysin (SYP), 24 a presynaptic-vesicle marker present throughout the axon terminals of cones 25 M A N U S C R I P T
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and rods (Fernandez-Sanchez et al., 2011) . GNB3 antibody was used to stain 1 ON-bipolar cells (Fernandez-Bueno et al., 2012) . In 3-month-old untreated 2 P23H rats, only an isolated immunoreactive punctate structure for SYP staining 3 was found, indicating loss of photoreceptor axon terminals and giving the OPL 4 the appearance of a discontinuous plexus (Fig. 6B, 6E ; arrows). In the 5 remaining cones of peripheral retina, mislocated SYP staining was found along 6 the whole cell, from axon terminals to outer segments ( Fig. 6E; arrowheads) . By 7 contrast, in HU210-treated P23H rats, a continuous strip of labeled 8 photoreceptor terminals could be observed ( Fig. 6C, 6F ; arrows), indicating 9 photoreceptor terminal preservation. Double staining for SYP and GNB3 10 revealed synaptic contacts between rod spherules (labeled for SYP) and the 11 dendritic tips of ON-bipolar cells (labeled for GNB3) in HU210-treated animals 12 (Fig. 6C, 6F ). In comparison, fewer of such contacts were observed in vehicle-13 administered P23H rats (Fig. 6B, 6E ). For quantification of these effects, we 14 measured the relative area of SYP immunostaining in the OPL (surface of 15 positive staining per mm of retinal section). As shown in Fig. 3E horizontal cell subtype described in the rat retina can be identified using 1 antibodies against calbindin. In wild-type rats, calbindin labeling reveals a 2 punctate staining of dendritic arborization protruding from horizontal cell bodies 3 and connecting with cone axon terminals, together with thin tangential axonal 4 elongations in the OPL, ending in an extensive arborization connecting with 5 rods (Fig. 7A, arrows) . In 3-month-old P23H rats, a retraction and loss of 6 horizontal cell dendritic tips was found ( Fig. 7B; arrows) , concomitantly with the 7 decrease of stained photoreceptor rows. By contrast, in HU210-treated rat 8 retinas, a higher number of horizontal cell bodies and terminals could be 9 observed ( Fig. 7C; arrows) . 10
To explore whether preservation of the dendritic arborization in horizontal 11 cells correlated with preservation of synaptic connectivity in the OPL, we used 12 antibodies against bassoon. Typical bassoon-immunoreactive spots were 13 observed, with a horseshoe morphology corresponding to rod spherules ( showed numerous pairings between photoreceptor axons and horizontal cell 16 terminals in HU210-treated animals ( Fig. 7I ; arrows) as compared to fewer 17 contacts observed in untreated P23H rats ( Fig. 7H; The present study demonstrates that systemic administration of the 2 cannabinoid HU210 is capable of preserving retinal structure and function in 3 homozygous P23H transgenic rats, a model of autosomal dominant RP. This is 4 the first time that cannabinoid therapy has been assayed in RP. We have 5 focused our study not only on photoreceptor morphology and function, but also 6 on the secondary effects on photoreceptor connectivity and the structure of 7 inner retinal cell layers. The slow retinal degeneration that takes place in P23H 8 line 3 rats (Cuenca et al., 2004; Pinilla et al., 2005 ) makes this animal model 9 closer to the human condition than other P23H lines and genetic mouse 10 models, thus giving our results additional clinical relevance. 11
In this study, we found that HU210 therapy in P23H rats ameliorated the 12 loss of both rods and cones characteristic of these animals and preserved their 13 inflammatory actions (Fernandez-Ruiz et al., 2007) . HU210 has similar affinity 17 for CB1 and CB2 receptors (Pertwee, 1999) , whose immunoreactivity has been 18 found in the retina of rodents and primates (Bouskila et al., 2012; Bouskila et 19 al., 2013; Cecyre et al., 2013; Lopez et al., 2011; Straiker et al., 1999a; Yazulla, 20 2008; Yazulla et al., 1999) . Furthermore, evidence of cannabinoid function has 21 been provided in ganglion cells (Lalonde et al., 2006; Middleton and Protti, 22 2011), bipolar cells (Straiker et al., 1999b; Yazulla et al., 2000) and 23
photoreceptors (Fan and Yazulla, 2003; Straiker and Sullivan, 2003) . HU210 24 has been shown to be 100 to 800 times more potent than THC (Ottani and 25
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Giuliani, 2001), having a slightly longer duration of action than the analog 1 natural cannabinoid (Little et al., 1989; Ottani and Giuliani, 2001) 
